Clinical Trials Logo

Clinical Trial Summary

The purpose of the protocol, is to assess the safety and efficacy profile of IPN59011 compared to a placebo. IPN59011 is expected to work longer than product already marketed in the treatment of subjects with moderate to severe facial wrinkles.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04736745
Study type Interventional
Source Ipsen
Contact
Status Terminated
Phase Phase 1
Start date February 10, 2021
Completion date October 28, 2022